By Melanie Senior
On one level, Solvay SA 's €1.3 billion ($1.7 billion) all-cash acquisition of Fournier Pharma makes perfect sense:...
Mid-Sized European M&A Fills Earnings Gap--And More?
Solvay's acquisition of France's Fournier suggests that there is value within Europe's family-owned, domestically-focused groups, and at good prices. The deal will boost Solvay's earnings until its own pipeline matures, although some question the potential for longer-term synergies.